Vetco visited PET SEOUL KAHA 2018 in Korea with the representatives of Taiwan Veterinary Association this August. This trip was not merely to introduce the new anti-cancer drug- Antican® to global, but also to learn more about the Korean veterinary market.
It was such an honor to be welcomed and had a photo with the President of KAHA, Dr. Hur (left), organizer of PET SEOUL KAHA 2018. During the event, many companies showed high interests in Antican® and future collaboration.
After the event, we visited the animal hospital of the President of Incheon Veterinary Medical Association, Dr. Yun (middle), and had a profound discussion on “Canine Cancer in Korea” with the veterinarians.
This had been a fruitful trip, Korean veterinarians are highly interested in Antican®, as a promising cancer treatment option to them. In near future, what kind of story will Antican® create in Korea? Please stay tuned for more updates.